Pacific Wealth Management’s AbbVie ABBV Stock Holding History

Pacific Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.36M	Sell	38,452 -275	-0.7%	-$61K	4.5%	5
2025 Q4	$8.85M	Sell	38,727 -785	-2%	-$179K	4.11%	6
2025 Q3	$9.15M	Hold	39,512	–	–	4.61%	5
2025 Q2	$7.33M	Sell	39,512 -137	-0.3%	-$25.5K	3.62%	8
2025 Q1	$8.31M	Sell	39,649 -237	-0.6%	-$46.1K	4.57%	6
2024 Q4	$7.09M	Sell	39,886 -370	-0.9%	-$68K	3.75%	7
2024 Q3	$7.95M	Sell	40,256 -142	-0.4%	-$26.5K	3.7%	7
2024 Q2	$6.93M	Buy	40,398 +727	+2%	+$120K	3.53%	6
2024 Q1	$6.15M	Hold	39,671	–	–	3.51%	7
2023 Q4	$6.15M	Buy	39,671 +99	+0.3%	+$14.4K	3.51%	7
2023 Q3	$5.9M	Buy	39,572 +378	+1%	+$55.5K	3.88%	6
2023 Q2	$5.28M	Sell	39,194 -2,564	-6%	-$376K	3.43%	8
2023 Q1	$6.66M	Buy	41,758 +408	+1%	+$62.4K	4.27%	6
2022 Q4	$6.68M	Buy	41,350 +544	+1%	+$83.4K	4.91%	7
2022 Q3	$5.48M	Buy	+40,806	New	+$5.86M	4.86%	7

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacific Wealth Management's ABBV Position: Q1 2026 in Review

Pacific Wealth Management reduced its AbbVie (ABBV) stake by 0.71% in Q1 2026, selling an estimated $61K and leaving 38,452 shares worth $8.36M. The position accounts for 4.5% of the portfolio, ranked #5.

Pacific Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. The position peaked at $9.15M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pacific Wealth Management held 38,452 shares of AbbVie worth $8.36M as of Q1 2026.
Pacific Wealth Management sold 275 AbbVie shares in Q1 2026, an estimated $61K.
AbbVie made up 4.5% of Pacific Wealth Management's portfolio in Q1 2026, its #5 holding.
Pacific Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
Pacific Wealth Management's AbbVie position peaked at $9.15M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pacific Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.